168 related articles for article (PubMed ID: 35620274)
1. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study.
Ruan SM; Cheng MQ; Huang H; Hu HT; Li W; Xie XY; Lu MD; Kuang M; Lin MX; Wang W
J Hepatocell Carcinoma; 2022; 9():437-451. PubMed ID: 35620274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.
Hu YX; Shen JX; Han J; Mao SY; Mao RS; Li Q; Li F; Guo ZX; Zhou JH
Front Oncol; 2021; 11():641195. PubMed ID: 33912456
[TBL] [Abstract][Full Text] [Related]
4. Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
Lyshchik A; Fetzer DT; Kono Y; Wilson SR; Dietrich CF; Clevert DA; Meloni MF; Jang HJ; Kim TK; Lee JM; Minami Y; Kudo M; Piscaglia F
Radiology; 2024 May; 311(2):e232369. PubMed ID: 38805727
[TBL] [Abstract][Full Text] [Related]
5. LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features.
Wang D; Zhang Y; Lyu R; Jia K; Xu PJ
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38605217
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
[TBL] [Abstract][Full Text] [Related]
7. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation.
Zhang Y; Wang J; Li H; Zheng T; Jiang H; Li M; Song B
Ann Transl Med; 2020 Mar; 8(6):388. PubMed ID: 32355832
[TBL] [Abstract][Full Text] [Related]
8. Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.
Wang H; Cao J; Fan H; Huang J; Zhang H; Ling W
Quant Imaging Med Surg; 2023 Aug; 13(8):4919-4932. PubMed ID: 37581040
[TBL] [Abstract][Full Text] [Related]
9. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
13. Comparison of modified CEUS LI-RADS with sonazoid and CT/MRI LI-RADS for diagnosis of hepatocellular carcinoma.
Sugimoto K; Saito K; Shirota N; Kamiyama N; Sakamaki K; Takahashi H; Wada T; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
Hepatol Res; 2022 Aug; 52(8):730-738. PubMed ID: 35570681
[TBL] [Abstract][Full Text] [Related]
14. The comparison of contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI LI-RADS for nodules ≤2 cm in patients at high risk for HCC: a prospective study.
Qin Z; Zhou Y; Zhang X; Ding J; Zhou H; Wang Y; Zhao L; Chen C; Jing X
Front Oncol; 2024; 14():1345981. PubMed ID: 38774417
[TBL] [Abstract][Full Text] [Related]
15. Combination of CT/MRI LI-RADS with CEUS can improve the diagnostic performance for HCCs.
Zhou Y; Ding J; Qin Z; Long L; Zhang X; Wang F; Chen C; Wang Y; Zhou H; Jing X
Eur J Radiol; 2022 Apr; 149():110199. PubMed ID: 35196614
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.
Kim YY; Kim MJ; Yoon JK; Shin J; Roh YH
AJR Am J Roentgenol; 2022 Mar; 218(3):484-493. PubMed ID: 34585608
[No Abstract] [Full Text] [Related]
17. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
18. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
20. CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma.
Lv K; Cao X; Dong Y; Geng D; Zhang J
Ann Transl Med; 2021 Jul; 9(13):1076. PubMed ID: 34422988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]